AUBAGIOHCP.COM SERVER
We discovered that the main page on aubagiohcp.com took two thousand two hundred and thirty-four milliseconds to come up. I detected a SSL certificate, so our parsers consider this site secure.
NAME SERVERS
ns1.sanofi-synthelabo.com
ns2.sanofi-synthelabo.com
ns3.sanofi-synthelabo.com
ns4.sanofi-synthelabo.com
WEBSITE ICON

SERVER SOFTWARE
We detected that this website is weilding the Microsoft-IIS/8.5 server.HTML TITLE
AUBAGIO teriflunomide Official Healthcare Professional SiteDESCRIPTION
The official HCP site for AUBAGIO teriflunomide, a once-daily prescription medicine used to treat relapsing forms of MS, from Sanofi Genzyme. See full safety info.PARSED CONTENT
The site aubagiohcp.com had the following on the web page, "Teriflunomide is indicated for the treatment of patients with relapsing." I noticed that the website said " WARNING HEPATOTOXICITY AND RISK OF TERATOGENICITY." They also stated " Severe liver injury including fatal liver failure has been reported in patients treated. With leflunomide, which is indicated for rheumatoid arthritis. Please see Important Safety Information. For your patients with relapsing MS. AUBAGIO 14 mg is the only." The meta header had Aubagio as the first keyword. This keyword was followed by teriflunomide, multiple sclerosis treatment, and relapsing multiple sclerosis which isn't as urgent as Aubagio. The other words the site used was MS treatment. relapsing remitting multiple sclerosis is also included but could not be viewed by search engines.